questionsmedicales.fr
Facteurs biologiques
Pigments biologiques
Porphyrines
Uroporphyrines
Uroporphyrines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Methicillin-Resistant Staphylococcus aureus
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Uroporphyrines : Questions médicales les plus fréquentes",
"headline": "Uroporphyrines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Uroporphyrines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-01",
"dateModified": "2025-03-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Uroporphyrines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Porphyrines",
"url": "https://questionsmedicales.fr/mesh/D011166",
"about": {
"@type": "MedicalCondition",
"name": "Porphyrines",
"code": {
"@type": "MedicalCode",
"code": "D011166",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Uroporphyrines",
"alternateName": "Uroporphyrins",
"code": {
"@type": "MedicalCode",
"code": "D014578",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Juliana Bragazzi Cunha",
"url": "https://questionsmedicales.fr/author/Juliana%20Bragazzi%20Cunha",
"affiliation": {
"@type": "Organization",
"name": "Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA. bragazzi@umich.edu."
}
},
{
"@type": "Person",
"name": "Jared S Elenbaas",
"url": "https://questionsmedicales.fr/author/Jared%20S%20Elenbaas",
"affiliation": {
"@type": "Organization",
"name": "Medical Scientist Training Program, Washington University, Saint Louis, 63110, USA."
}
},
{
"@type": "Person",
"name": "Dhiman Maitra",
"url": "https://questionsmedicales.fr/author/Dhiman%20Maitra",
"affiliation": {
"@type": "Organization",
"name": "Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA."
}
},
{
"@type": "Person",
"name": "Ning Kuo",
"url": "https://questionsmedicales.fr/author/Ning%20Kuo",
"affiliation": {
"@type": "Organization",
"name": "Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA."
}
},
{
"@type": "Person",
"name": "Rodrigo Azuero-Dajud",
"url": "https://questionsmedicales.fr/author/Rodrigo%20Azuero-Dajud",
"affiliation": {
"@type": "Organization",
"name": "Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "LYZ2-SH3b as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus.",
"datePublished": "2023-09-13",
"url": "https://questionsmedicales.fr/article/37704938",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12866-023-03002-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Capillary electrophoretic methods for classification of methicillin-resistant Staphylococcus aureus (MRSA) clones.",
"datePublished": "2022-08-31",
"url": "https://questionsmedicales.fr/article/36089316",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.aca.2022.340305"
}
},
{
"@type": "ScholarlyArticle",
"name": "Relationship between mortality and molecular epidemiology of methicillin-resistant Staphylococcus aureus bacteremia.",
"datePublished": "2022-07-08",
"url": "https://questionsmedicales.fr/article/35802589",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0271115"
}
},
{
"@type": "ScholarlyArticle",
"name": "Engineering a \"detect and destroy\" skin probiotic to combat methicillin-resistant Staphylococcus aureus.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36520793",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0276795"
}
},
{
"@type": "ScholarlyArticle",
"name": "Proton Motive Force Inhibitors Are Detrimental to Methicillin-Resistant Staphylococcus aureus Strains.",
"datePublished": "2022-08-09",
"url": "https://questionsmedicales.fr/article/35943153",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/spectrum.02024-22"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Pigments biologiques",
"item": "https://questionsmedicales.fr/mesh/D010860"
},
{
"@type": "ListItem",
"position": 4,
"name": "Porphyrines",
"item": "https://questionsmedicales.fr/mesh/D011166"
},
{
"@type": "ListItem",
"position": 5,
"name": "Uroporphyrines",
"item": "https://questionsmedicales.fr/mesh/D014578"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Uroporphyrines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Uroporphyrines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Uroporphyrines",
"description": "Comment diagnostiquer une accumulation d'uroporphyrines ?\nQuels tests sont utilisés pour évaluer les uroporphyrines ?\nQuels symptômes peuvent indiquer un excès d'uroporphyrines ?\nLes tests génétiques sont-ils nécessaires pour le diagnostic ?\nQuelle est l'importance de l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Uroporphyrines",
"description": "Quels sont les symptômes courants des troubles liés aux uroporphyrines ?\nLes uroporphyrines provoquent-elles des problèmes cutanés ?\nY a-t-il des symptômes psychologiques associés ?\nLes douleurs abdominales sont-elles fréquentes ?\nComment les symptômes varient-ils selon les individus ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Uroporphyrines",
"description": "Comment prévenir les troubles liés aux uroporphyrines ?\nUne alimentation spécifique peut-elle aider ?\nLes examens réguliers sont-ils nécessaires ?\nLe stress influence-t-il les troubles des uroporphyrines ?\nLes vaccinations sont-elles importantes pour ces patients ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Uroporphyrines",
"description": "Quels traitements sont disponibles pour les troubles des uroporphyrines ?\nLes transfusions sanguines sont-elles une option de traitement ?\nLa photothérapie est-elle efficace pour ces troubles ?\nLes médicaments peuvent-ils réduire les niveaux d'uroporphyrines ?\nY a-t-il des traitements alternatifs recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Uroporphyrines",
"description": "Quelles complications peuvent survenir avec les uroporphyrines ?\nLes troubles hépatiques sont-ils une complication possible ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles réversibles ?\nLes complications psychologiques sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Uroporphyrines",
"description": "Quels sont les principaux facteurs de risque des troubles des uroporphyrines ?\nL'alcoolisme est-il un facteur de risque ?\nLes médicaments peuvent-ils augmenter le risque ?\nLes infections sont-elles un facteur de risque ?\nLe sexe influence-t-il le risque de troubles ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une accumulation d'uroporphyrines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par analyse d'urine pour mesurer les niveaux d'uroporphyrines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les uroporphyrines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de laboratoire, comme l'électrophorèse, sont utilisés pour évaluer les uroporphyrines."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un excès d'uroporphyrines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des douleurs abdominales et des troubles cutanés peuvent indiquer un excès."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils nécessaires pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent être nécessaires pour confirmer des troubles héréditaires."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier des facteurs de risque et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des troubles liés aux uroporphyrines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleurs abdominales, photosensibilité et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les uroporphyrines provoquent-elles des problèmes cutanés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent causer des éruptions cutanées et une sensibilité accrue au soleil."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes psychologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'anxiété et la dépression peuvent être associés à ces troubles."
}
},
{
"@type": "Question",
"name": "Les douleurs abdominales sont-elles fréquentes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les douleurs abdominales sont un symptôme fréquent des troubles des uroporphyrines."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les individus ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent varier en fonction de la gravité et du type de trouble métabolique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux uroporphyrines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les déclencheurs comme l'alcool et certains médicaments peut aider à prévenir les crises."
}
},
{
"@type": "Question",
"name": "Une alimentation spécifique peut-elle aider ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en glucides et faible en graisses peut aider à prévenir les symptômes."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils nécessaires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à surveiller les niveaux d'uroporphyrines et prévenir les complications."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il les troubles des uroporphyrines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut aggraver les symptômes et déclencher des crises chez certains patients."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes pour ces patients ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent prévenir des infections qui pourraient aggraver l'état de santé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles des uroporphyrines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des modifications diététiques et des médicaments pour gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Les transfusions sanguines sont-elles une option de traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les transfusions peuvent être utilisées dans certains cas pour traiter les complications."
}
},
{
"@type": "Question",
"name": "La photothérapie est-elle efficace pour ces troubles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La photothérapie peut aider à réduire les symptômes cutanés liés à la photosensibilité."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils réduire les niveaux d'uroporphyrines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent aider à réduire les niveaux d'uroporphyrines dans le corps."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs recommandés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs comme l'acupuncture peuvent être envisagés pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les uroporphyrines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions cutanées, des douleurs chroniques et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les troubles hépatiques sont-ils une complication possible ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles hépatiques peuvent survenir en raison de l'accumulation d'uroporphyrines."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité de vie en provoquant douleur et incapacité fonctionnelle."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications psychologiques comme l'anxiété peuvent survenir en raison de la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque des troubles des uroporphyrines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies hépatiques et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "L'alcoolisme est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'alcoolisme peut aggraver les symptômes et augmenter le risque de complications."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils augmenter le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent déclencher des crises chez les personnes sensibles."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent exacerber les symptômes et augmenter le risque de complications."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de troubles ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles des uroporphyrines sont plus fréquents chez les femmes que chez les hommes."
}
}
]
}
]
}
Enzybiotics are promising alternatives to conventional antibiotics for drug-resistant infections. Exolysins, as a class of enzybiotics, show antibacterial effects against methicillin-resistant Staphyl...
This study designed a chimeric exolysin by fusing the Cell-binding domain (SH3b) from Lysostaphin with the lytic domain (LYZ2) from the gp61 enzyme. Subsequently, LYZ2-SH3b was cloned and expressed in...
Analysis of bioinformatics showed that LYZ2-SH3b was stable, soluble, and non-allergenic. Protein purification was performed with a 0.8 mg/ml yield for LYZ2-SH3b. The plate lysis assay results indicat...
The study suggests that phage endolysins, such as LYZ2-SH3b, may represent a promising new approach to treating MRSA infections, particularly in cases where antibiotic resistance is a concern. But fur...
This study describes differentiation of methicillin-resistant Staphylococcus aureus (MRSA) isolates belonging to different genotype groups by the combination of electrophoretic techniques, transient i...
Staphylococcus aureus is the primary cause of bacteremia, and methicillin-resistant S. aureus bacteremia is associated with a high mortality rate. Methicillin-resistant S. aureus clones are widespread...
The prevalence and virulence of pathogens such as methicillin-resistant Staphylococcus (S.) aureus (MRSA), which can cause recurrent skin infections, are of significant clinical concern. Prolonged ant...
Methicillin-resistant Staphylococcus aureus (MRSA) strains are tolerant of conventional antibiotics, making them extremely dangerous. Previous studies have shown the effectiveness of proton motive for...
Methicillin-resistant Staphylococcus aureus (MRSA) can cause serious infections and empiric treatment regimens in children frequently include an anti-MRSA antibiotic. Studies in adults have demonstrat...
This was a single-site, retrospective cohort study of pediatric patients admitted with a suspected infectious diagnosis who had an MNS performed during their hospitalization between June 1, 2018 and N...
This study identified 172 patients who met the inclusion criteria. Eleven (6.4%) nasal swabs were positive for MRSA and 10 (5.8%) microbiological cultures from suspected sources of infection were iden...
MNS has a high NPV and low PPV in children. MNS can be utilized as an antimicrobial stewardship tool to guide the safe de-escalation of anti-MRSA antibiotics in children....
Necrotizing pneumonia caused by methicillin-resistant Staphylococcus aureus can lead to the formation of pneumatoceles in the lungs. Standard treatment guidelines are not available due to the rarity o...
Baby H. required prolonged respiratory support and supplemental oxygen to maintain appropriate oxygen saturation parameters for infants more than 34 weeks' gestation corrected. He was found to have mu...
Baby H. was a former 32.2-week gestation male infant diagnosed with pneumonia caused by necrotizing methicillin-resistant Staphylococcus aureus leading to pneumatocele formation in both lungs....
Baby H. was managed with aggressive antibiotic therapy and then was conservatively managed until he received a tracheostomy tube on day of life (DOL) 75 to prepare for discharge home....
Baby H. was discharged from the neonatal intensive care unit (NICU) on DOL 113 with a tracheostomy tube for prolonged mechanical ventilatory support and a gastrostomy tube for nutrition. Numerous foll...
While methicillin-resistant Staphylococcus aureus pneumatoceles are uncommon in the NICU setting, it is important for neonatal care providers to be aware of the causes and treatment choices currently ...
Methicillin-resistant Staphylococcus aureus (MRSA), a globally widespread pathogen that is highly resistant to antibiotics, can lead to serious infection, and has fairly limited treatment options. Ove...
Staphylococcus aureus, a commensal bacterium, colonizes the skin and mucous membranes of approximately 30% of the human population. Apart from conventional resistance mechanisms, one of the pathogenic...
Analyzing non-repetitive clinical isolates of MRSA collected from seven provinces and cities in China between 2014 and 2020, it was observed that 53.2% of the MRSA isolates exhibited varying degrees o...
MRSA strains with biofilm production capability warrant increased vigilance....
Methicillin-resistant Staphylococcus aureus (MRSA) infections impose a considerable burden on health systems, yet there is remarkable variation in the global incidence and epidemiology of MRSA. The MA...
Operational definitions of success were defined in consortium meetings to compose a balanced strain collection of successful and sporadic MRSA isolates. Isolates were subjected to antimicrobial suscep...
Heterogeneity of MRSA isolate collections across countries hampered the use of a unified operational definition of success; therefore, country-specific approaches were used to establish the MACOTRA st...
Our results are the strongest yet to associate MRSA antibiotic resistance profiles and antibiotic usage with the incidence of infection and successful clonal spread, which varied by country. Harmonize...